Asymmetric dimethlyarginine directly promotes chronic kidney disease progression: Evidence from a mendelian randomization approach in the GCKD study. (September 2016) - Schneider, M.; Mieth, M.; Titze, S.; Kronenberg, F.; Li, Y.; Maas, R.; Eckardt, K.U.